TopFIND 4.0

Q8IVA1: Purkinje cell protein 2 homolog

General Information

Protein names
- Purkinje cell protein 2 homolog

Gene names PCP2
Organism Homo sapiens
Protease Family
Protease ID
Chromosome location
UniProt ID Q8IVA1

1

N-termini

1

C-termini

0

Cleavages

0

Substrates

Sequence

        10         20         30         40         50         60 
MMDQEEKTEE GSGPCAEAGS PDQEGFFNLL SHVQGDRMEG QRCSLQAGPG QTTKSQSDPT 
        70         80         90        100        110        120 
PEMDSLMDML ASTQGRRMDD QRVTVSSLPG FQPVGSKDGA QKRAGTLSPQ PLLTPQDPTA 
       130    
LGFRRNSSPQ PPTQAP

Isoforms

- Isoform 2 of Purkinje cell protein 2 homolog

Sequence View

        10         20         30         40         50         60 
MMDQEEKTEE GSGPCAEAGS PDQEGFFNLL SHVQGDRMEG QRCSLQAGPG QTTKSQSDPT 
        70         80         90        100        110        120 
PEMDSLMDML ASTQGRRMDD QRVTVSSLPG FQPVGSKDGA QKRAGTLSPQ PLLTPQDPTA 
       130    
LGFRRNSSPQ PPTQAP



Filter Information:


(REFRESH)

Directness:


Physiological Relevance:


Evidence Codes:


Methodology:


Perturbation of System:


Biological System:


Protease Assignment Confidence:


Evidence Names:


Database:


Lab:



Protein Neighborhood

Domains & Features

1 N-termini - 1 C-termini - 0 Cleavages - 0 Substrates

N-termini

    Name Sequence Position Modification Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMID)
    Q8IVA1-1-unknown MMDQEE... 1 inferred from electronic annotation electronic annotation UniProtKB inferred from uniprot

C-termini

    Name Sequence Position Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)
    ...PTQAP 136 inferred from electronic annotation electronic annotation UniProtKB inferred from uniprot

Cleavages

    Protease Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)

Substrates

    Substrate Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)